Chicago Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.57M Buy
20,052
+81
+0.4% +$6.34K 0.04% 150
2025
Q1
$1.45M Buy
19,971
+1,563
+8% +$113K 0.04% 143
2024
Q4
$1.36M Sell
18,408
-83,763
-82% -$6.2M 0.04% 144
2024
Q3
$6.74M Sell
102,171
-42,395
-29% -$2.8M 0.19% 73
2024
Q2
$13.4M Sell
144,566
-2,159
-1% -$199K 0.4% 51
2024
Q1
$14M Sell
146,725
-10,805
-7% -$1.03M 0.43% 47
2023
Q4
$12M Sell
157,530
-18,829
-11% -$1.44M 0.43% 47
2023
Q3
$12.2M Sell
176,359
-3,063
-2% -$212K 0.57% 43
2023
Q2
$16.9M Sell
179,422
-997
-0.6% -$94K 0.76% 37
2023
Q1
$14.9M Sell
180,419
-263,351
-59% -$21.8M 0.74% 37
2022
Q4
$33.1M Sell
443,770
-47,241
-10% -$3.52M 1.83% 22
2022
Q3
$40.6M Sell
491,011
-4,167
-0.8% -$344K 2.35% 14
2022
Q2
$47.1M Buy
495,178
+29,062
+6% +$2.76M 2.6% 10
2022
Q1
$54.9M Buy
466,116
+15,255
+3% +$1.8M 2.36% 12
2021
Q4
$58.4M Sell
450,861
-6,205
-1% -$804K 2.18% 19
2021
Q3
$51.7M Sell
457,066
-3,393
-0.7% -$384K 1.96% 22
2021
Q2
$47.7M Sell
460,459
-875
-0.2% -$90.6K 1.86% 24
2021
Q1
$38.6M Buy
461,334
+5,945
+1% +$497K 1.63% 30
2020
Q4
$41.5M Buy
455,389
+107,585
+31% +$9.81M 1.86% 28
2020
Q3
$27.8M Buy
347,804
+30
+0% +$2.4K 1.43% 31
2020
Q2
$24M Buy
347,774
+3,992
+1% +$276K 1.39% 30
2020
Q1
$21.6M Sell
343,782
-111,714
-25% -$7.02M 1.74% 24
2019
Q4
$35.4M Sell
455,496
-11,229
-2% -$873K 2.16% 14
2019
Q3
$34.2M Sell
466,725
-170,628
-27% -$12.5M 2.29% 8
2019
Q2
$39.2M Buy
637,353
+22,287
+4% +$1.37M 2.51% 5
2019
Q1
$39.2M Sell
615,066
-13,272
-2% -$846K 2.67% 5
2018
Q4
$32.1M Sell
628,338
-4,332
-0.7% -$221K 2.62% 5
2018
Q3
$36.7M Buy
632,670
+72,393
+13% +$4.2M 2.54% 6
2018
Q2
$27.2M Buy
560,277
+178,176
+47% +$8.65M 2.19% 9
2018
Q1
$17.8M Buy
+382,101
New +$17.8M 2.37% 10